Thermo Fisher Scientific Wins Innovation Award in Informatics for Second Consecutive Year
News Jul 16, 2009
Thermo Fisher Scientific Inc. has announced that it has been named the winner of the Microsoft Corporation 2009 Pharmaceutical and Life Sciences Innovation Award in the Discovery and Product Innovation category, for the second consecutive year.
The award honors best-in-class companies for their use of Microsoft-based solutions. Microsoft selected Norway-based Hunt Research Centre and Biobank in recognition of its use of Thermo Scientific Nautilus to better manage and analyze the large amounts of real-time medical data and provide valuable insight into disease status and progression.
Thermo Scientific Nautilus LIMS provided HUNT with a comprehensive biobanking solution to gather, store, manage, track and retrieve large amounts of data securely, and yield real-time, dependable analysis and reports.
The Award, announced at the Drug Information Association’s (DIA) 45th Annual Meeting in San Diego, was presented to Thermo Fisher Scientific and Hunt Research Centre and Biobank to acknowledge the technology solutions used for one of the largest population-based health study ever performed.
Hunt Research Centre and Biobank implemented Thermo Scientific Nautilus LIMS to automate their process from the clinic to the laboratory in order to accommodate for the vast scope and progressively increasing study complexity. Building on the Microsoft technology, the Thermo Fisher and Hunt application is used on one of the largest health studies ever performed.
Three studies spanning 25 years have been run on an integrated family and personal database of approximately 100,000 people from Norway. The studies support epidemiological, clinical and preventative medical research and offer valuable insight into disease status and progression. Hunt paired Thermo Scientific Nautilus LIMS with Microsoft technology which included InfoPath and SQL Server to increase throughput and automation.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
The architecture of each person’s brain is unique, and differences may influence how quickly people can complete various cognitive tasks.o learn more, scientists are developing a new tool — computational models of the brain — to simulate how the structure of the brain may impact brain activity and, ultimately, human behavior.READ MORE
2nd International Conference on Computational Biology and Bioinformatics
May 17 - May 18, 2019